Kazuko Matsuda - 24 Jun 2021 Form 4 Insider Report for MEDICINOVA INC (MNOV)

Role
Chief Medical Officer, Director
Signature
/s/ Yuichi Iwaki, attorney-in-fact
Issuer symbol
MNOV
Transactions as of
24 Jun 2021
Transactions value $
$256,622
Form type
4
Filing time
28 Jun 2021, 16:50:59 UTC
Next filing
25 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNOV Common Stock Options Exercise $118,247 +46,554 +29% $2.54 206,746 24 Jun 2021 Direct
transaction MNOV Common Stock Options Exercise $138,375 +56,250 +27% $2.46 262,996 24 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNOV Employee Stock Option (Right to Buy) Options Exercise $0 -46,554 -100% $0* 0 24 Jun 2021 Common Stock 46,554 $2.54 Direct F1
transaction MNOV Employee Stock Option (Right to Buy) Options Exercise $0 -56,250 -100% $0* 0 24 Jun 2021 Common Stock 56,250 $2.46 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested.
F2 The option was granted on 8/3/2011, was subject to vesting based on achievement of performance criteria and vested in full on 6/14/2012.